Key Event Details

  • Event: Investor Conference Call
  • Purpose: Discussion on the unaudited financial results for the quarter and half year ended September 30, 2026 (Q2 and H1 FY27).
  • Date: Tuesday, October 27, 2026
  • Time: 05:00 pm IST
  • Structure: The call will commence with a brief management discussion on the financial performance, followed by an interactive Question & Answer session.

Access Information for Conference Call

Pre-registration: Participants are advised to pre-register at a provided link to receive dial-in numbers, a passcode, and a PIN via email.

Conference Dial-In Numbers:

  • India: +91 22 6280 1141 / +91 22 7115 8042
  • USA Toll Free: 1 866 746 2133
  • UK Toll Free: 0 808 101 1573
  • Singapore Toll Free: 800 101 2045
  • Hong Kong Toll Free: 800 964 448

Audio Link: A live audio link will be available on the company's website at: https://jubilantingrevia.com/investors/financials/quarterly-results

Company Background (As Provided)

Jubilant Ingrevia Limited is described as an integrated global Specialty Chemicals & CDMO (Contract Development and Manufacturing Organization) company. Its key attributes include:

  • Portfolio: Over 130+ products.
  • Key Products: Pyridine & Picolines, Pyridine derivatives, Acetic Anhydride, Vitamin-B3.
  • Customers: Serves Pharmaceutical, Nutrition, Agrochemical, Consumer, Semiconductor, and Industrial customers.
  • Global Reach: Customers in the US, EU, Japan, Middle East, South East Asia, and domestic Indian market.
  • Manufacturing: 50 plants across 5 manufacturing facilities in India.
  • Workforce: Over 2,300 employees.
  • R&D: Three R&D centres employing 150 scientists.
  • Certifications & Rankings: Responsible Care certified. Ranked highly in global ESG indices (Ecovadis and Dow Jones Sustainability Index). Recognized by the World Economic Forum (WEF) and entered its Global Lighthouse Network (GLN) in 2024 for deployment of 4IR technologies.

Document and Contact Information

  • Letter Date: October 14, 2026
  • Investor Contact at Jubilant Ingrevia: Pavleen Taneja (Ph: +91-120 4361000; E-mail: pavleen.taneja@jubl.com)
  • Media Contact (CDR India): Siddharth Rangnekar (Ph: +91 97699 19966) / Mit Shah (Ph: +91 99201 68314; E-mail: siddharth@cdr-india.com, mit@cdr-india.com)

Financial Impact

Financial impact is not quantified in this disclosure. The purpose is to announce the schedule for the discussion of results, not to report the results themselves.